ArticleOncology and therapy2025

Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) DLBCL with CAR T Cell Therapy: A Vodcast and Case Example.

Gloria Iacoboni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.